Latest Stories
Featured Stories
Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.
Feedback
All Stories
Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.
Shalini Garg
IBS (Irritable Bowel Syndrome)
Delhi
This story is a powerful testament to resilience and hope. It narrates the journey of Shalini Gar…
Gaurav Kumar
Chronic Calcific Pancreatitis
Delhi
For over a decade, Gaurav Kumar was trapped in a relentless cycle of agony and hospitalization, b…
Avichal Dixit
Chronic Calcific Pancreatitis
Pilibhit, Uttar Pradesh
This narrative traces the rapid systemic degradation faced by Avichal Dixit, a talented young stu…
Ravinder Kumar
Recurrent Acute Pancreatitis, Diabetes
Panipat, Haryana
This story is a powerful testament to resilience and hope. It narrates the journey of Ravinder Ku…
Rohit Gupta
Chronic Pancreatitis
New Delhi
This is the story of Rohit Gupta , whose resilience transformed a seemingly insurmountable clinic…
Vivaan Guleria
Acute on Chronic Pancreatitis
Dharamshala, Himachal Pradesh
This story is a powerful testament to resilience and hope. It narrates the journey of Vivaan Gule…
Research
Our Research
At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.
Demographic Pattern of Pancreatitis Patients in India – A Hospital-based Study
A hospital-based study on 2,050 pancreatitis patients across India found that 83% were male, with an average age of 24 years, and 75% aged between 19–45. Alcohol use was reported by 33.6% and tobacco by 18.4%, while genetic and gallstone-related causes accounted for 8.8% and 5% respectively. The findings suggest emerging lifestyle and regional risk factors, but broader studies are needed for definitive insights.
Case studies on prophylactic ayurvedic therapy in migraine patients
Ayurvedic treatment has shown effectiveness in managing migraines. A protocol (ATP) with herbo-mineral formulations, regular meals, and sleep reduced migraine frequency and intensity in a study of nine patients. Five reported significant improvement after 120 days, with no serious side effects. Ongoing research is further validating the findings.
Ayurvedic preparation in the treatment of nutritional anemia
A pilot study on 600 anemic women showed the highest hemoglobin gain (1.8 g%) with a combination of Ayurvedic preparations SS and Ayas, followed by Ayas (1.6 g%), SS (1.5 g%), and IFA tablets (1.1 g%). SS, a non-iron Ayurvedic preparation, improved iron absorption and showed promising results with minimal side effects.
Clinical Intervention of Ayurvedic Treatment in the Patients of Recurrent Acute/Chronic Pancreatitis
The study of 1233 acute pancreatitis patients found that 12.9% experienced oral feeding intolerance (OFI). Risk factors included younger age, male sex, alcohol use, smoking, non-biliary etiology, and SIRS at 48h. SIRS at 48h (OR 2.85) and non-biliary etiology (OR 1.77) were independently linked to OFI, with biliary etiology being protective.
Relevance of metal based Ayurvedic formulations in the management of recurrent acute/ chronic pancreatitis
This study reports on 250 cases of Recurrent Acute Pancreatitis (RAP) and Chronic Pancreatitis (CP) treated with an Ayurvedic herbo-mineral formulation, along with a balanced diet and lifestyle changes. Significant improvement was seen in patients who completed the treatment.
Acute Promyelocytic Leukemia: 37 Years Long Ongoing Survival in a de novo Patient with Metal-Based Ayurvedic Treatment
Acute promyelocytic leukemia (APML) is a subtype of leukemia marked by anemia, infections, and bleeding. It is diagnosed through bone marrow tests and the PML-RARα fusion gene. Recent treatments with ATRA and arsenic trioxide have improved survival rates, but challenges like side effects and relapses remain. A 1982 case of a patient who survived 37 years without standard treatment suggests potential alternative therapies.